Innovations in radiation therapy (RT) for breast cancer

Breast

Volumn 18, Issue SUPPL.3, 2009, Pages

  Lee, Larissa J ^a   Harris, Jay R ^b  

^a HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Intensity modulated radiation; Local recurrence; Local regional recurrence; Radiation therapy; radiotherapy; therapy Accelerated partial breast; V30; V5

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; TAMOXIFEN;

ADJUVANT THERAPY; ARTICLE; BRACHYTHERAPY; BREAST CANCER; CANADA; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; CONSENSUS DEVELOPMENT; DOSIMETRY; ESTHETICS; EXTERNAL BEAM RADIOTHERAPY; HEART DEATH; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; INTRAOPERATIVE RADIOTHERAPY; LYMPH NODE METASTASIS; MASTECTOMY; MEDICAL EXPERT; PARTIAL MASTECTOMY; PATIENT SAFETY; PRIORITY JOURNAL; PROCESS MODEL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RECURRENCE RISK; RISK REDUCTION; TREATMENT OUTCOME; TREATMENT PLANNING; UNITED STATES;

EID: 71749116903     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(09)70284-X     Document Type: Article

References (72)

1. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366 9503 (2005) 2087-2106
2. Overgaard M., Jensen M.B., Overgaard J., et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353 9165 (1999) 1641-1648
3. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337 14 (1997) 949-955
4. Ragaz J., Olivotto I.A., Spinelli J.J., et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97 2 (2005) 116-126
5. Pierce L.J., Butler J.B., Martel M.K., et al. Postmastectomy radiotherapy of the chest wall: dosimetric comparison of common techniques. Int J Radiat Oncol Biol Phys 52 5 (2002) 1220-1230
6. Taylor C.W., Nisbet A., McGale P., and Darby S.C. Cardiac exposures in breast cancer radiotherapy: 1950s-1990s. Int J Radiat Oncol Biol Phys 69 5 (2007) 1484-1495
7. Houghton J., Baum M., and Haybittle J.L. Role of radiotherapy following total mastectomy in patients with early breast cancer. The Closed Trials Working Party of the CRC Breast Cancer Trials Group. World J Surg 18 1 (1994) 117-122
8. Host H., Brennhovd I.O., and Loeb M. Postoperative radiotherapy in breast cancer - long-term results from the Oslo study. Int J Radiat Oncol Biol Phys 12 5 (1986) 727-732
9. Haybittle J.L., Brinkley D., Houghton J., A'Hern R.P., and Baum M. Postoperative radiotherapy and late mortality: evidence from the Cancer Research Campaign trial for early breast cancer. BMJ 298 6688 (1989) 1611-1614
10. Darby S.C., McGale P., Taylor C.W., and Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 6 8 (2005) 557-565
11. Paszat L.F., Mackillop W.J., Groome P.A., Boyd C., Schulze K., and Holowaty E. Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. J Clin Oncol 16 8 (1998) 2625-2631
12. Lind P.A., Pagnanelli R., Marks L.B., et al. Myocardial perfusion changes in patients irradiated for left-sided breast cancer and correlation with coronary artery distribution. Int J Radiat Oncol Biol Phys 55 4 (2003) 914-920
13. Correa C.R., Litt H.I., Hwang W.T., Ferrari V.A., Solin L.J., and Harris E.E. Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer. J Clin Oncol 25 21 (2007) 3031-3037
14. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365 9472 (2005) 1687-1717
15. Punglia R.S., Morrow M., Winer E.P., and Harris J.R. Local therapy and survival in breast cancer. N Engl J Med 356 23 (2007) 2399-2405
16. Kyndi M., Overgaard M., Nielsen H.M., Sorensen F.B., Knudsen H., and Overgaard J. High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c. Radiother Oncol 90 1 (2009) 74-79
17. Perou C.M., Sorlie T., Eisen M.B., et al. Molecular portraits of human breast tumours. Nature 406 6797 (2000) 747-752
18. Sorlie T., Perou C.M., Tibshirani R., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98 19 (2001) 10869-10874
19. Brenton J.D., Carey L.A., Ahmed A.A., and Caldas C. Molecular classification and molecular forecasting of breast cancer: ready for clinical application?. J Clin Oncol 23 29 (2005) 7350-7360
20. Nguyen P.L., Taghian A.G., Katz M.S., et al. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 26 14 (2008) 2373-2378
21. Kyndi M., Sorensen F.B., Knudsen H., Overgaard M., Nielsen H.M., and Overgaard J. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. J Clin Oncol 26 9 (2008) 1419-1426
22. Piccart-Gebhart M.J., Procter M., Leyland-Jones B., et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 353 16 (2005) 1659-1672
23. Romond E.H., Perez E.A., Bryant J., et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 353 16 (2005) 1673-1684
24. Raj K.A., Evans E.S., Prosnitz R.G., et al. Is there an increased risk of local recurrence under the heart block in patients with left-sided breast cancer?. Cancer J (Sudbury, MA) 12 4 (2006) 309-317
25. Chen R.C., Lin N.U., Golshan M., Harris J.R., and Bellon J.R. Internal mammary nodes in breast cancer: diagnosis and implications for patient management-asystematic review. J Clin Oncol 26 30 (2008) 4981-4989
26. Krueger E.A., Schipper M.J., Koelling T., Marsh R.B., Butler J.B., and Pierce L.J. Cardiac chamber and coronary artery doses associated with postmastectomy radiotherapy techniques to the chest wall and regional nodes. Int J Radiat Oncol Biol Phys 60 4 (2004) 1195-1203
27. Hurkmans C.W., Saarnak A.E., Pieters B.R., Borger J.H., and Bruinvis I.A. An improved technique for breast cancer irradiation including the locoregional lymph nodes. Int J Radiat Oncol Biol Phys 47 5 (2000) 1421-1429
28. Gray J.R., McCormick B., Cox L., and Yahalom J. Primary breast irradiation in large-breasted or heavy women: analysis of cosmetic outcome. Int J Radiat Oncol Biol Phys 21 2 (1991) 347-354
29. Merchant T.E., and McCormick B. Prone position breast irradiation. Int J Radiat Oncol Biol Phys 30 1 (1994) 197-203
30. Algan O., Fowble B., McNeeley S., and Fein D. Use of the prone position in radiation treatment for women with early stage breast cancer. Int J Radiat Oncol Biol Phys 40 5 (1998) 1137-1140
31. Alonso-Basanta M., MacDonald S., Lymberis S., et al. Dosimetric comparisons of supine versus prone radiation: implications on normal tissue toxicity. Int J Radiat Oncol Biol Phys 63 (2005) S182-S183
32. Griem K.L., Fetherston P., Kuznetsova M., Foster G.S., Shott S., and Chu J. Three-dimensional photon dosimetry: a comparison of treatment of the intact breast in the supine and prone position. Int J Radiat Oncol Biol Phys 57 3 (2003) 891-899
33. Chino J.P., and Marks L.B. Prone positioning causes the heart to be displaced anteriorly within the thorax: implications for breast cancer treatment. Int J Radiat Oncol Biol Phys 70 3 (2008) 916-920
34. Parhar P., Constantine C., Racsa-Alamgir M., et al. Preliminary results of NYU 05-181, a prospective trial to establish the individual optimal positioning for breast radiotherapy. Int J Radiat Oncol Biol Phys 66 3 (2006) S177
35. Lymberis S., Parhar P., Yee D., et al. Results of prospective trial to determine optimal patient positioning prone vs. supine for whole breast radiation. Int J Radiat Oncol Biol Phys 72 1 (2008) S509
36. Stegman L.D., Beal K.P., Hunt M.A., Fornier M.N., and McCormick B. Long-term clinical outcomes of whole-breast irradiation delivered in the prone position. Int J Radiat Oncol Biol Phys 68 1 (2007) 73-81
37. Vicini F.A., Sharpe M., Kestin L., et al. Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 54 5 (2002) 1336-1344
38. Kestin L.L., Sharpe M.B., Frazier R.C., et al. Intensity modulation to improve dose uniformity with tangential breast radiotherapy: initial clinical experience. Int J Radiat Oncol Biol Phys 48 5 (2000) 1559-1568
39. Donovan E., Bleakley N., Denholm E., et al. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 82 3 (2007) 254-264
40. Pignol J.P., Olivotto I., Rakovitch E., et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 26 13 (2008) 2085-2092
41. Gulyban A., Kovacs P., Sebestyen Z., et al. Multisegmented tangential breast fields: a rational way to treat breast cancer. Strahlenther Onkol 184 5 (2008) 262-269
42. Lohr F., El-Haddad M., Dobler B., et al. Potential effect of robust and simple IMRT approach for left-sided breast cancer on cardiac mortality. Int J Radiat Oncol Biol Phys 74 1 (2009) 73-80
43. Beckham W.A., Popescu C.C., Patenaude V.V., Wai E.S., and Olivotto I.A. Is multibeam IMRT better than standard treatment for patients with left-sided breast cancer?. Int J Radiat Oncol Biol Phys 69 3 (2007) 918-924
44. Chen M.H., Cash E.P., Danias P.G., et al. Respiratory maneuvers decrease irradiated cardiac volume in patients with left-sided breast cancer. J Cardiovasc Magn Reson 4 2 (2002) 265-271
45. Chen M.H., Chuang M.L., Bornstein B.A., Gelman R., Harris J.R., and Manning W.J. Impact of respiratory maneuvers on cardiac volume within left-breast radiation portals. Circulation 96 10 (1997) 3269-3272
46. Lu H.M., Cash E., Chen M.H., et al. Reduction of cardiac volume in left-breast treatment fields by respiratory maneuvers: a CT study. Int J Radiat Oncol Biol Phys 47 4 (2000) 895-904
47. Remouchamps V.M., Letts N., Vicini F.A., et al. Initial clinical experience with moderate deep-inspiration breath hold using an active breathing control device in the treatment of patients with left-sided breast cancer using external beam radiation therapy. Int J Radiat Oncol Biol Phys 56 3 (2003) 704-715
48. Sixel K.E., Aznar M.C., and Ung Y.C. Deep inspiration breath hold to reduce irradiated heart volume in breast cancer patients. Int J Radiat Oncol Biol Phys 49 1 (2001) 199-204
49. Remouchamps V.M., Vicini F.A., Sharpe M.B., Kestin L.L., Martinez A.A., and Wong J.W. Significant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast irradiation. Int J Radiat Oncol Biol Phys 55 2 (2003) 392-406
50. Pedersen A.N., Korreman S., Nystrom H., and Specht L. Breathing adapted radiotherapy of breast cancer: reduction of cardiac and pulmonary doses using voluntary inspiration breath-hold. Radiother Oncol 72 1 (2004) 53-60
51. Korreman S.S., Pedersen A.N., Nottrup T.J., Specht L., and Nystrom H. Breathing adapted radiotherapy for breast cancer: comparison of free breathing gating with the breath-hold technique. Radiother Oncol 76 3 (2005) 311-318
52. Letts N., Martinez A., Langenstein L., et al. Two years experience utilizing moderate deep inspiration breath-hold (MDIBH) to reduce cardiac dose in left sided breast irradiation. Int J Radiat Oncol Biol Phys 60 (2004) S392-S393
53. Whelan T., MacKenzie R., Julian J., et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 94 15 (2002) 1143-1150
54. Whelan T., Pignol J., Julian J., et al. Long-term results of a randomized trial of accelerated hypofractionated whole breast irradiation following breast conserving surgery in women with node-negative breast cancer. Int J Radiat Oncol Biol Phys 70 1 (2008) S28
55. Bartelink H., Horiot J.C., Poortmans P.M., et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 25 22 (2007) 3259-3265
56. Yarnold J., Ashton A., Bliss J., et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol 75 1 (2005) 9-17
57. Owen J.R., Ashton A., Bliss J.M., et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 7 6 (2006) 467-471
58. Bentzen S.M., Agrawal R.K., Aird E.G., et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 371 9618 (2008) 1098-1107
59. Bentzen S.M., Agrawal R.K., Aird E.G., et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 9 4 (2008) 331-341
60. Vicini F.A., and Arthur D.W. Breast brachytherapy: North American experience. Semin Radiat Oncol 15 2 (2005) 108-115
61. Major T., Frohlich G., Lovey K., Fodor J., and Polgar C. Dosimetric experience with accelerated partial breast irradiation using image-guided interstitial brachytherapy. Radiother Oncol 90 1 (2009) 48-55
62. Vicini F., Beitsch P.D., Quiet C.A., et al. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI). Cancer 112 4 (2008) 758-766
63. Stewart A.J., O'Farrell D.A., Cormack R.A., et al. Dose volume histogram analysis of normal structures associated with accelerated partial breast irradiation delivered by high dose rate brachytherapy and comparison with whole breast external beam radiotherapy fields. Radiat Oncol 3 (2008) 39
64. Veronesi U., Orecchia R., Luini A., et al. A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer 37 17 (2001) 2178-2183
65. Veronesi U., Orecchia R., Luini A., et al. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery: experience with 590 cases. Ann Surg 242 1 (2005) 101-106
66. Intra M., Leonardi C., Luini A., et al. Full-dose intraoperative radiotherapy with electrons in breast surgery: broadening the indications. Arch Surg 140 10 (2005) 936-939
67. Vicini F.A., Chen P., Wallace M., et al. Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 69 4 (2007) 1124-1130
68. Chen P., Gustafson G., Mitchell C., et al. Three-year clinical experience utilizing 3D-conformal radiation therapy to deliver accelerated partial breast irradiation (APBI). Int J Radiat Oncol Biol Phys 72 1 (2008) S3-S4
69. Vicini F.A., Remouchamps V., Wallace M., et al. Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 57 5 (2003) 1247-1253
70. Taghian A., El-Din M.A., Smith B., et al. Interim results of a Phase I/II trial of 3D-conformal external beam accelerated partial breast irradiation in patients with early breast cancer. Int J Radiat Oncol Biol Phys 72 1 (2008) S4
71. Kozak K.R., Doppke K.P., Katz A., and Taghian A.G. Dosimetric comparison of two different three-dimensional conformal external beam accelerated partial breast irradiation techniques. Int J Radiat Oncol Biol Phys 65 2 (2006) 340-346
72. Smith B.D., Arthur D.W., Buchholz T.A., et al. Accelerated partial breast irradiation consensus statement from the American Society of Therapeutic Radiology and Oncology. Int J Radiat Oncol Biol Phys 74 4 (2009) 987-1001